ACI.FHH-(D1Rat324-D1Rat156)/Eur |
body weight |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
body mass |
male |
173 days-180 days |
8 |
|
284.0 |
g |
5.0 |
14.14 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67680 |
751 |
ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
kidney glomerulus integrity trait |
male |
173 days-180 days |
8 |
|
5.0 |
% |
1.0 |
2.83 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
|
|
67956 |
751 |
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
kidney glomerulus integrity trait |
male |
173 days-180 days |
10 |
|
2.0 |
% |
1.0 |
3.16 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
|
|
67957 |
751 |
ACI.FHH-(D1Rat324-D1Rat156)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
kidney glomerulus integrity trait |
male |
173 days-180 days |
8 |
|
9.0 |
% |
3.0 |
8.49 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
|
|
67958 |
751 |
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
kidney glomerulus integrity trait |
male |
173 days-180 days |
9 |
|
8.0 |
% |
2.0 |
6.0 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
|
|
67960 |
751 |
ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
kidney glomerulus integrity trait |
male |
91 days-98 days |
21 |
|
3.2 |
% |
0.39 |
1.8 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
|
|
69158 |
1128 |
ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur |
body weight |
unilateral nephrectomy |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168 days-175 days |
12 |
|
304.0 |
g |
4.0 |
13.86 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
|
67902 |
832 |
ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168 days-175 days |
9 |
|
29.0 |
% |
4.0 |
12.0 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
68885 |
832 |
SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 13 |
|
1.65 |
mg/dl |
0.14 |
0.5 |
serum creatinine analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100637 |
2499 |
SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 12 |
|
0.93 |
mg/dl |
0.05 |
0.17 |
serum creatinine analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100640 |
2499 |
SD |
serum parathyroid hormone level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood parathyroid hormone amount |
female |
0 days
| 13 |
|
3496.0 |
pg/ml |
862.0 |
3107.99 |
serum parathyroid hormone analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100647 |
2499 |
SD |
serum parathyroid hormone level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood parathyroid hormone amount |
female |
0 days
| 12 |
|
170.0 |
pg/ml |
60.0 |
207.85 |
serum parathyroid hormone analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100650 |
2499 |
SHR/NCrlCrlj |
plasma angiotensin II level to plasma angiotensin I level ratio |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin II amount |
male |
126 days
| 8 |
|
0.77 |
null |
0.05 |
0.14 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
blood ang II level |
101279 |
2583 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 11 |
|
76.0 |
mg/dl |
1.0 |
3.32 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
99970 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 17 |
|
312.0 |
mg/dl |
24.0 |
98.95 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
99972 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 16 |
|
3.19 |
ml/min/100g |
0.13 |
0.52 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99994 |
2378 |
MW |
body weight |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 5 |
|
234.0 |
g |
17.0 |
38.01 |
body measuring method |
|
0.0 |
unx |
70 |
days |
|
|
|
101155 |
2581 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 5 |
undefined |
94.0 |
mmHg |
3.0 |
6.71 |
tail cuff plethysmography |
|
0.0 |
unx |
14 |
days |
|
|
|
101160 |
2581 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 5 |
|
26.0 |
mg/dl |
1.0 |
2.24 |
blood urea nitrogen analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101179 |
2581 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 5 |
|
32.0 |
mg/dl |
3.0 |
6.71 |
blood urea nitrogen analysis |
|
0.0 |
unx |
70 |
days |
|
|
|
101188 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 7 |
|
18.0 |
mg/d |
4.0 |
10.58 |
Bradford protein assay |
|
0.0 |
unx |
70 |
days |
|
|
|
101200 |
2581 |
MW |
glomerular filtration rate |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 6 |
|
0.57 |
ml/min |
0.07 |
0.17 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
70 |
days |
|
|
|
101204 |
2581 |
SHR/NCrlCrlj |
blood sodium level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood sodium amount |
male |
126 days
| 8 |
|
142.0 |
mmol/l |
2.0 |
5.66 |
automated serum sodium test |
|
0.0 |
unx |
42 |
days |
|
|
|
101239 |
2583 |
SD |
food intake rate |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
eating behavior trait |
male |
0 days
| 8 |
|
23.0 |
g/d |
2.12 |
6.0 |
unspecified method |
|
0.0 |
unx |
28 |
days |
|
change from surgery weight |
|
101612 |
2602 |
SD |
heart wet weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
heart mass |
male |
0 days
| 8 |
|
1.33 |
g |
0.05 |
0.13 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101619 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 8 |
|
283.0 |
mg/d |
52.33 |
148.0 |
urine protein analysis |
|
0.0 |
unx |
28 |
days |
|
|
|
101623 |
2602 |
SD |
plasma potassium level |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
blood potassium amount |
male |
0 days
| 7 |
|
6.2 |
mmol/l |
0.15 |
0.4 |
ex vivo blood analysis |
|
0.0 |
unx |
28 |
days |
|
|
|
101597 |
2602 |
SD |
body weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 5 |
|
285.0 |
g |
6.71 |
15.0 |
body weighing method |
|
0.0 |
unx |
13 |
days |
|
|
|
101537 |
2602 |
SD |
plasma aldosterone level |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
blood aldosterone amount |
male |
0 days
| 11 |
|
526.0 |
pg/ml |
78.39 |
260.0 |
plasma aldosterone analysis |
|
0.0 |
unx |
13 |
days |
|
- |
|
101556 |
2602 |
SD |
plasma renin activity level |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
renin activity |
male |
0 days
| 5 |
|
13.3 |
ng/ml/h |
5.5 |
12.3 |
radioimmunoassay |
|
0.0 |
unx |
13 |
days |
|
|
|
101565 |
2602 |
SD |
plasma renin activity level |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
renin activity |
male |
0 days
| 5 |
|
5.2 |
ng/ml/h |
2.24 |
5.0 |
radioimmunoassay |
|
0.0 |
unx |
13 |
days |
|
|
|
101566 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 6 |
|
312.0 |
g |
9.8 |
24.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
101574 |
2602 |
SD |
left kidney wet weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney mass |
male |
0 days
| 7 |
|
1.91 |
g |
0.21 |
0.55 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
remnant kidney |
|
101580 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 7 |
|
203.0 |
mg/d |
38.93 |
103.0 |
urine protein analysis |
|
0.0 |
unx |
28 |
days |
|
|
|
101592 |
2602 |
SHR/NCrlCrlj |
serum creatinine level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood creatinine amount |
male |
126 days
| 8 |
|
0.67 |
mg/dl |
0.04 |
0.11 |
serum creatinine analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101247 |
2583 |
SHR/NCrlCrlj |
serum creatinine level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood creatinine amount |
male |
126 days
| 9 |
|
0.74 |
mg/dl |
0.04 |
0.12 |
serum creatinine analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101248 |
2583 |
SHR/NCrlCrlj |
blood urea nitrogen level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood urea nitrogen amount |
male |
126 days
| 5 |
|
52.0 |
mg/dl |
4.0 |
8.94 |
blood urea nitrogen analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101253 |
2583 |
SHR/NCrlCrlj |
plasma renin activity level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
renin activity |
male |
126 days
| 8 |
|
9.8 |
ng/ml/h |
1.7 |
4.81 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
|
101263 |
2583 |
SHR/NCrlCrlj |
plasma aldosterone level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood aldosterone amount |
male |
126 days
| 9 |
|
369.0 |
pg/ml |
54.0 |
162.0 |
plasma aldosterone analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101268 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin I level |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin I amount |
male |
126 days
| 5 |
|
169.0 |
pg/ml |
33.0 |
73.79 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
|
101270 |
2583 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.52 |
ml/min/100g |
0.03 |
0.07 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99947 |
2378 |
ACI.FHH-(rs105487995-rs105373896)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91 days
| 8 |
|
62.94 |
mg/d |
7.34 |
20.76 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-1 |
|
100052 |
2400 |
ACI.FHH-(rgdv393055223-rs198922144)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91 days
| 7 |
|
173.13 |
mg/d |
18.71 |
49.5 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-4 |
|
100055 |
2400 |
ACI.FHH-(rs105373896-rgdv253272372)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91 days
| 6 |
|
41.34 |
mg/d |
4.81 |
11.78 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-6 |
|
100057 |
2400 |
ACI.FHH-(rs105487995-rs106411696)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91 days
| 8 |
|
33.72 |
mg/d |
6.92 |
19.57 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-2 |
|
100061 |
2400 |
ACI.FHH-(rgdv393055223-rs198076037)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91 days
| 7 |
|
27.46 |
mg/d |
3.8 |
10.05 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-5 |
|
100064 |
2400 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
8.8 |
mmHg/ml/min |
0.5 |
1.41 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99962 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 6 |
|
8.8 |
mmHg/ml/min |
0.5 |
1.22 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99964 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 8 |
|
41.62 |
ml/d |
9.07 |
25.66 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
|
99968 |
2378 |
SBH/Ygl |
urine total protein excretion rate |
unilateral nephrectomy (for 150 days) |
Yagil Y, et al., Physiol Genomics. 2010 Nov 29;42A(4):301-16. Epub 2010 Sep 28. |
total urine protein amount |
female |
170 days
| 7 |
|
202.0 |
mg/d |
24.0 |
63.5 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
|
106689 |
3037 |
SHR/FubRkb |
plasma cystatin C level |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
blood cystatin C amount |
male |
168 days
| 15 |
|
0.07 |
mg/l |
0.0 |
0.01 |
automated plasma protein analysis |
|
0.0 |
|
0 |
|
|
|
|
109567 |
3148 |
SHR/FubRkb |
right kidney wet weight |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
kidney mass |
male |
168 days
| 15 |
|
1.63 |
g |
0.05 |
0.19 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
|
109555 |
3148 |
SHR-Chr 8MWF/Rkb |
right kidney wet weight |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
kidney mass |
male |
168 days
| 15 |
|
1.59 |
g |
0.04 |
0.15 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
|
109556 |
3148 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 11 |
|
2.4 |
g/kg |
0.1 |
0.33 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107450 |
2378 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 17 |
|
3.2 |
g/kg |
0.1 |
0.41 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107452 |
2378 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 16 |
|
261.0 |
g |
7.0 |
28.0 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
|
107448 |
2378 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 17 |
|
13.2 |
x 10E3 um2 |
3.3 |
13.61 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
|
|
107511 |
2378 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 16 |
|
3.1 |
g/kg |
0.1 |
0.4 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107454 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 17 |
|
17.0 |
x 10E3 um2 |
4.1 |
16.9 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
|
107462 |
2378 |
ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168 days-175 days |
12 |
|
30.0 |
% |
3.0 |
10.39 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
68876 |
832 |
ACI/Eur |
urine total protein excretion rate to body weight ratio |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
total urine protein amount |
male |
91 days-98 days |
21 |
|
5.9 |
mg/d/100 g |
0.59 |
2.7 |
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
urine TOTAL protein excretion rate to body weight ratio |
|
69154 |
1128 |
ACI.FHH-(rs105487995-rs106411696)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91 days
| 8 |
|
81.88 |
mg/d |
16.62 |
47.01 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-2 |
|
100053 |
2400 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 16 |
|
45.8 |
% |
0.5 |
2.0 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
|
99978 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 16 |
|
49.25 |
ml/d |
5.18 |
20.74 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
|
100004 |
2378 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 7 |
undefined |
118.0 |
mmHg |
2.0 |
5.29 |
tail cuff plethysmography |
|
0.0 |
unx |
42 |
days |
|
|
|
101163 |
2581 |
MW |
mean arterial blood pressure |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 5 |
undefined |
87.0 |
mmHg |
4.0 |
8.94 |
vascular indwelling catheter method |
|
0.0 |
unx |
70 |
days |
|
|
|
101174 |
2581 |
SD |
systolic blood pressure |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 6 |
undefined |
186.0 |
mmHg |
10.61 |
26.0 |
tail cuff plethysmography |
|
0.0 |
unx |
28 |
days |
|
|
|
101586 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (for 14 days) then spironolactone (5.56 mg/kg/d) (for 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
192.0 |
mmHg |
7.07 |
20.0 |
tail cuff plethysmography |
|
0.0 |
unx |
14 |
days |
|
|
|
101616 |
2602 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 7 |
|
2.16 |
ml/min/100g |
0.18 |
0.48 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99950 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.26 |
null |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99956 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 6 |
|
0.21 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99959 |
2378 |
ACI/Eur |
body weight |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
body mass |
male |
173 days-180 days |
8 |
|
308.0 |
g |
5.0 |
14.14 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67678 |
751 |
FHH/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
kidney glomerulus integrity trait |
male |
91 days-98 days |
26 |
|
52.1 |
% |
2.29 |
11.7 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
|
|
69159 |
1128 |
ACI/Eur |
plasma creatinine level |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood creatinine amount |
male |
173 days-180 days |
11 |
|
0.77 |
mg/dl |
0.05 |
0.15 |
plasma creatinine analysis by Jaffe reaction without deproteinization with spectrophotometric readout |
|
0.0 |
|
0 |
|
Jaffe method colorimetric spectrometry |
|
|
68005 |
751 |
ACI.FHH-(D1Rat384-D1Rat156)/Eur |
body weight |
unilateral nephrectomy |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168 days-175 days |
12 |
|
305.0 |
g |
8.0 |
27.71 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
|
67900 |
832 |
FHH/Eur |
body weight |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
body mass |
male |
91 days-98 days |
26 |
|
310.0 |
g |
2.94 |
15.0 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
|
|
69140 |
1128 |
ACI/Eur |
systolic blood pressure |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
arterial blood pressure trait |
male |
91 days-98 days |
21 |
|
113.0 |
mmHg |
1.96 |
9.0 |
tail cuff plethysmography |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
|
|
69141 |
1128 |
ACI.FHH-(D1Rat384-D1Rat156)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168 days-175 days |
12 |
|
13.0 |
% |
2.0 |
6.93 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
68875 |
832 |
SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 13 |
|
0.3 |
ml/min |
0.03 |
0.11 |
serum creatinine analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100642 |
2499 |
SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 12 |
|
0.56 |
ml/min |
0.03 |
0.1 |
serum creatinine analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100643 |
2499 |
SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 10 |
|
0.35 |
ml/min |
0.02 |
0.06 |
serum creatinine analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100644 |
2499 |
SD |
serum parathyroid hormone level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood parathyroid hormone amount |
female |
0 days
| 12 |
|
371.0 |
pg/ml |
100.0 |
346.41 |
serum parathyroid hormone analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100648 |
2499 |
SD |
left kidney wet weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney mass |
male |
0 days
| 5 |
|
1.49 |
g |
0.1 |
0.23 |
post excision weight measurement |
|
0.0 |
unx |
13 |
days |
|
remnant kidney |
|
101546 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 11 |
|
121.0 |
mg/d |
16.28 |
54.0 |
urine protein analysis |
|
0.0 |
unx |
13 |
days |
|
- |
|
101552 |
2602 |
SD |
plasma aldosterone level |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
blood aldosterone amount |
male |
0 days
| 5 |
|
487.0 |
pg/ml |
50.98 |
114.0 |
plasma aldosterone analysis |
|
0.0 |
unx |
13 |
days |
|
|
|
101558 |
2602 |
SD |
adrenal gland weight |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
adrenal gland mass |
male |
0 days
| 11 |
|
63.0 |
mg |
1.21 |
4.0 |
post excision weight measurement |
|
0.0 |
unx |
13 |
days |
|
- |
|
101560 |
2602 |
SD |
adrenal gland weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
adrenal gland mass |
male |
0 days
| 5 |
|
60.0 |
mg |
3.13 |
7.0 |
post excision weight measurement |
|
0.0 |
unx |
13 |
days |
|
|
|
101562 |
2602 |
SD |
change in body weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 6 |
|
106.0 |
g |
10.61 |
26.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
change from surgery weight |
|
101578 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 7 |
|
30.0 |
mg/d |
5.67 |
15.0 |
urine protein analysis |
|
0.0 |
unx |
28 |
days |
|
|
|
101593 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 6 |
|
217.0 |
mg/d |
28.99 |
71.0 |
urine protein analysis |
|
0.0 |
unx |
28 |
days |
|
|
|
101594 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 8 |
|
300.0 |
g |
10.96 |
31.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
101608 |
2602 |
MW |
body weight |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 7 |
|
220.0 |
g |
9.0 |
23.81 |
body measuring method |
|
0.0 |
unx |
14 |
days |
|
|
|
101142 |
2581 |
MW |
body weight |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 7 |
|
260.0 |
g |
6.0 |
15.87 |
body measuring method |
|
0.0 |
unx |
42 |
days |
|
|
|
101146 |
2581 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 5 |
undefined |
95.0 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
|
0.0 |
unx |
42 |
days |
|
|
|
101164 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 6 |
|
313.0 |
mg/d |
40.0 |
97.98 |
Bradford protein assay |
|
0.0 |
unx |
42 |
days |
|
|
|
101195 |
2581 |
MW |
glomerular filtration rate |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 5 |
|
0.94 |
ml/min |
0.11 |
0.25 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
70 |
days |
|
|
|
101206 |
2581 |
SHR/NCrlCrlj |
blood sodium level |
unilateral nephrectomy (for 42 days) then vehicle control condition (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood sodium amount |
male |
126 days
| 5 |
|
140.0 |
mmol/l |
1.0 |
2.24 |
automated serum sodium test |
|
0.0 |
unx |
42 |
days |
|
|
|
101238 |
2583 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 16 |
|
44.5 |
% |
0.6 |
2.4 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
|
99979 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 11 |
|
0.23 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99985 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 17 |
|
0.21 |
null |
0.01 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99987 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 17 |
|
3.3 |
ml/min/100g |
0.11 |
0.45 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99992 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 17 |
|
41.47 |
ml/d |
4.46 |
18.41 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
|
100002 |
2378 |
SD |
left kidney wet weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney mass |
male |
0 days
| 8 |
|
1.96 |
g |
0.16 |
0.44 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101613 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
190.0 |
mmHg |
9.9 |
28.0 |
tail cuff plethysmography |
|
0.0 |
unx |
28 |
days |
|
|
|
101618 |
2602 |
SD |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney glomerulus integrity trait |
male |
0 days
| 8 |
|
31.0 |
% |
5.66 |
16.0 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
28 |
days |
|
|
|
101629 |
2602 |
SHR/NCrlCrlj |
blood potassium level |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood potassium amount |
male |
126 days
| 5 |
|
5.7 |
mmol/l |
0.4 |
0.89 |
automated serum potassium test |
|
0.0 |
unx |
42 |
days |
|
|
|
101242 |
2583 |
SHR/NCrlCrlj |
blood potassium level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood potassium amount |
male |
126 days
| 5 |
|
4.6 |
mmol/l |
0.2 |
0.45 |
automated serum potassium test |
|
0.0 |
unx |
42 |
days |
|
|
|
101245 |
2583 |
SHR/NCrlCrlj |
serum creatinine level |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood creatinine amount |
male |
126 days
| 5 |
|
0.95 |
mg/dl |
0.08 |
0.18 |
serum creatinine analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101246 |
2583 |
SHR/NCrlCrlj |
serum creatinine level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood creatinine amount |
male |
126 days
| 5 |
|
0.92 |
mg/dl |
0.06 |
0.13 |
serum creatinine analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101249 |
2583 |
SHR/NCrlCrlj |
blood urea nitrogen level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood urea nitrogen amount |
male |
126 days
| 9 |
|
40.0 |
mg/dl |
2.0 |
6.0 |
blood urea nitrogen analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101252 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 14 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
98 days
| 15 |
|
0.36 |
ml/min/100g |
0.04 |
0.16 |
blood creatinine analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101254 |
2583 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 8 |
|
215.0 |
g |
10.0 |
28.28 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
99936 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 7 |
|
74.0 |
mg/dl |
2.0 |
5.29 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
99940 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 7 |
|
0.49 |
ml/min/100g |
0.03 |
0.08 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99945 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
2.32 |
ml/min/100g |
0.11 |
0.31 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99953 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 7 |
|
0.23 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99955 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 7 |
|
10.0 |
mmHg/ml/min |
0.6 |
1.59 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99960 |
2378 |
ACI/EurMcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91 days
| 9 |
|
68.52 |
mg/d |
7.28 |
21.84 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-1 |
|
100051 |
2400 |
ACI.FHH-(rgdv393055223-rs107095981)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91 days
| 5 |
|
93.07 |
mg/d |
13.96 |
31.22 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-3 |
|
100062 |
2400 |
ACI.FHH-(rs198076037-rs105278863)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91 days
| 5 |
|
69.44 |
mg/d |
7.49 |
16.75 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-7 |
|
100066 |
2400 |
SBN/Ygl |
urine total protein excretion rate |
unilateral nephrectomy (for 120 days) |
Yagil Y, et al., Physiol Genomics. 2010 Nov 29;42A(4):301-16. Epub 2010 Sep 28. |
total urine protein amount |
male |
140 days
| 6 |
|
78.0 |
mg/d |
12.0 |
29.39 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
|
106687 |
3037 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 16 |
|
267.0 |
g |
9.0 |
36.0 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
|
107449 |
2378 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 16 |
|
8.1 |
mg/g |
0.2 |
0.8 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107458 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 16 |
|
16.4 |
x 10E3 um2 |
4.1 |
16.4 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
|
107464 |
2378 |
ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur |
body weight |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168 days-175 days |
9 |
|
277.0 |
g |
6.0 |
18.0 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
|
67910 |
832 |
FHH/Eur |
systolic blood pressure |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
arterial blood pressure trait |
male |
91 days-98 days |
26 |
|
151.0 |
mmHg |
1.96 |
10.0 |
tail cuff plethysmography |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
|
|
69142 |
1128 |
ACI/Eur |
body weight |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
body mass |
male |
173 days-180 days |
11 |
|
292.0 |
g |
9.0 |
29.85 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67681 |
751 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.79 |
ml/min/100g |
0.03 |
0.08 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99946 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
9.2 |
mmHg/ml/min |
0.4 |
1.13 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99963 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 17 |
|
0.69 |
ml/min/100g |
0.03 |
0.13 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99982 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 16 |
|
0.22 |
null |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99988 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 16 |
|
3.15 |
ml/min/100g |
0.13 |
0.52 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99993 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 17 |
|
39.46 |
ml/d |
4.61 |
19.0 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
|
100001 |
2378 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 7 |
undefined |
118.0 |
mmHg |
2.0 |
5.29 |
tail cuff plethysmography |
|
0.0 |
unx |
14 |
days |
|
|
|
101159 |
2581 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 7 |
|
26.0 |
mg/dl |
1.0 |
2.65 |
blood urea nitrogen analysis |
|
0.0 |
unx |
70 |
days |
|
|
|
101187 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 7 |
|
23.0 |
mg/d |
2.0 |
5.29 |
Bradford protein assay |
|
0.0 |
unx |
42 |
days |
|
|
|
101196 |
2581 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 5 |
|
87.0 |
mg/d |
12.52 |
28.0 |
urine protein analysis |
|
0.0 |
unx |
13 |
days |
|
|
|
101554 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 7 |
|
309.0 |
g |
18.9 |
50.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
101572 |
2602 |
SD |
left kidney wet weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney mass |
male |
0 days
| 7 |
|
1.47 |
g |
0.07 |
0.18 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
remnant kidney |
|
101581 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 8 |
|
315.0 |
g |
9.55 |
27.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
101607 |
2602 |
SD |
food intake rate |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
eating behavior trait |
male |
0 days
| 8 |
|
19.0 |
g/d |
2.83 |
8.0 |
unspecified method |
|
0.0 |
unx |
28 |
days |
|
|
|
101611 |
2602 |
SD |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney glomerulus integrity trait |
male |
0 days
| 7 |
|
4.7 |
% |
1.97 |
5.2 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
28 |
days |
|
|
|
101605 |
2602 |
ACI.FHH-(D1Rat324-D1Rat156)/Eur |
plasma albumin level |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood albumin amount |
male |
173 days-180 days |
8 |
|
27.3 |
g/l |
0.9 |
2.55 |
bromocresol green-based urine albumin analysis with spectrophotometric readout |
|
0.0 |
|
0 |
|
bromocresol green |
|
|
68028 |
751 |
ACI/Eur |
urine albumin excretion rate to body weight ratio |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
urine albumin amount |
male |
91 days-98 days |
21 |
|
3.2 |
mg/d/100 g |
0.5 |
2.3 |
bromocresol green-based urine albumin analysis with spectrophotometric readout |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
|
|
69156 |
1128 |
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur |
plasma creatinine level |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood creatinine amount |
male |
173 days-180 days |
10 |
|
0.58 |
mg/dl |
0.02 |
0.07 |
plasma creatinine analysis by Jaffe reaction without deproteinization with spectrophotometric readout |
|
0.0 |
|
0 |
|
Jaffe method colorimetric spectrometry |
|
|
68003 |
751 |
ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168 days-175 days |
12 |
|
15.0 |
% |
3.0 |
10.39 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
68874 |
832 |
ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168 days-175 days |
12 |
|
12.0 |
% |
2.0 |
6.93 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
68877 |
832 |
SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 10 |
|
291.9 |
g |
6.4 |
20.24 |
body weighing method |
|
0.0 |
unx |
97 |
days |
|
|
|
100634 |
2499 |
SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 12 |
|
290.6 |
g |
6.8 |
23.56 |
body weighing method |
|
0.0 |
unx |
97 |
days |
|
|
|
100635 |
2499 |
SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 10 |
|
1.5 |
mg/dl |
0.11 |
0.35 |
serum creatinine analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100639 |
2499 |
SD |
serum parathyroid hormone level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood parathyroid hormone amount |
female |
0 days
| 10 |
|
629.0 |
pg/ml |
208.0 |
657.75 |
serum parathyroid hormone analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100649 |
2499 |
SHR/NCrlCrlj |
blood sodium level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood sodium amount |
male |
126 days
| 5 |
|
141.0 |
mmol/l |
2.0 |
4.47 |
automated serum sodium test |
|
0.0 |
unx |
42 |
days |
|
|
|
101241 |
2583 |
SHR/NCrlCrlj |
blood potassium level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood potassium amount |
male |
126 days
| 8 |
|
5.9 |
mmol/l |
0.2 |
0.57 |
automated serum potassium test |
|
0.0 |
unx |
42 |
days |
|
|
|
101243 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 14 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
98 days
| 9 |
|
0.34 |
ml/min/100g |
0.03 |
0.08 |
blood creatinine analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101256 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
126 days
| 5 |
|
0.23 |
ml/min/100g |
0.04 |
0.08 |
blood creatinine analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101261 |
2583 |
SHR/NCrlCrlj |
plasma renin activity level |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
renin activity |
male |
126 days
| 5 |
|
1.3 |
ng/ml/h |
0.2 |
0.45 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
|
101262 |
2583 |
SHR/NCrlCrlj |
plasma renin activity level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
renin activity |
male |
126 days
| 9 |
|
5.1 |
ng/ml/h |
0.5 |
1.5 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
|
101264 |
2583 |
SHR/NCrlCrlj |
plasma renin activity level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
renin activity |
male |
126 days
| 5 |
|
5.5 |
ng/ml/h |
1.7 |
3.8 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
|
101265 |
2583 |
SHR/NCrlCrlj |
plasma aldosterone level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood aldosterone amount |
male |
126 days
| 5 |
|
581.0 |
pg/ml |
92.0 |
205.72 |
plasma aldosterone analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101269 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin I level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin I amount |
male |
126 days
| 8 |
|
338.0 |
pg/ml |
28.0 |
79.2 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
|
101271 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin II level to plasma angiotensin I level ratio |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin II amount |
male |
126 days
| 9 |
|
0.34 |
null |
0.04 |
0.12 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
blood ang II level |
101280 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin II level to plasma angiotensin I level ratio |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin II amount |
male |
126 days
| 5 |
|
0.59 |
null |
0.04 |
0.09 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
blood ang II level |
101281 |
2583 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 16 |
|
0.66 |
ml/min/100g |
0.02 |
0.09 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99983 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 11 |
|
2.28 |
ml/min/100g |
0.07 |
0.23 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99990 |
2378 |
SD |
change in body weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 5 |
|
74.0 |
g |
7.6 |
17.0 |
body weighing method |
|
0.0 |
unx |
13 |
days |
|
change from surgery weight |
|
101541 |
2602 |
SD |
left kidney wet weight |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney mass |
male |
0 days
| 11 |
|
1.37 |
g |
0.07 |
0.23 |
post excision weight measurement |
|
0.0 |
unx |
13 |
days |
|
remnant kidney |
|
101544 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 5 |
undefined |
149.0 |
mmHg |
9.39 |
21.0 |
tail cuff plethysmography |
|
0.0 |
unx |
13 |
days |
|
|
|
101550 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 5 |
|
31.0 |
mg/d |
5.37 |
12.0 |
urine protein analysis |
|
0.0 |
unx |
13 |
days |
|
|
|
101553 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 7 |
undefined |
109.0 |
mmHg |
4.16 |
11.0 |
tail cuff plethysmography |
|
0.0 |
unx |
28 |
days |
|
|
|
101585 |
2602 |
SD |
heart wet weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
heart mass |
male |
0 days
| 7 |
|
1.33 |
g |
0.07 |
0.19 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101588 |
2602 |
SD |
change in body weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 8 |
|
59.0 |
g |
10.96 |
31.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
change from surgery weight |
|
101609 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (for 14 days) then spironolactone (5.56 mg/kg/d) (for 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 8 |
|
130.0 |
mg/d |
19.09 |
54.0 |
urine protein analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101622 |
2602 |
SD |
plasma potassium level |
unilateral nephrectomy (for 14 days) then spironolactone (5.56 mg/kg/d) (for 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
blood potassium amount |
male |
0 days
| 8 |
|
5.2 |
mmol/l |
0.14 |
0.4 |
ex vivo blood analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101626 |
2602 |
SD |
adrenal gland weight |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
adrenal gland mass |
male |
0 days
| 8 |
|
73.0 |
mg |
2.83 |
8.0 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101628 |
2602 |
MW |
body weight |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 6 |
|
213.0 |
g |
17.0 |
41.64 |
body measuring method |
|
0.0 |
unx |
70 |
days |
|
|
|
101153 |
2581 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 6 |
undefined |
125.0 |
mmHg |
4.0 |
9.8 |
tail cuff plethysmography |
|
0.0 |
unx |
42 |
days |
|
|
|
101162 |
2581 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 7 |
undefined |
122.0 |
mmHg |
2.0 |
5.29 |
tail cuff plethysmography |
|
0.0 |
unx |
70 |
days |
|
|
|
101168 |
2581 |
MW |
mean arterial blood pressure |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 7 |
undefined |
108.0 |
mmHg |
2.0 |
5.29 |
vascular indwelling catheter method |
|
0.0 |
unx |
70 |
days |
|
|
|
101173 |
2581 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 6 |
|
26.0 |
mg/dl |
2.0 |
4.9 |
blood urea nitrogen analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101177 |
2581 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 6 |
|
29.0 |
mg/dl |
2.0 |
4.9 |
blood urea nitrogen analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101181 |
2581 |
SHR/NCrlCrlj |
plasma angiotensin II level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin II amount |
male |
126 days
| 8 |
|
26.6 |
pg/ml |
3.6 |
10.18 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
blood ang II level |
101275 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin II level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin II amount |
male |
126 days
| 9 |
|
9.3 |
pg/ml |
1.4 |
4.2 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
blood ang II level |
101276 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin II level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin II amount |
male |
126 days
| 5 |
|
16.0 |
pg/ml |
3.0 |
6.71 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
blood ang II level |
101277 |
2583 |
ACI.FHH-(rgdv393055223-rs198076037)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91 days
| 7 |
|
67.24 |
mg/d |
4.02 |
10.64 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-5 |
|
100056 |
2400 |
ACI.FHH-(rs105373896-rgdv253272372)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91 days
| 6 |
|
16.35 |
mg/d |
3.01 |
7.37 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-6 |
|
100065 |
2400 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 6 |
|
367.0 |
mg/dl |
12.0 |
29.39 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
99944 |
2378 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 17 |
|
256.0 |
g |
5.0 |
20.62 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
|
107446 |
2378 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 17 |
|
3.5 |
g/kg |
0.1 |
0.41 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107451 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 17 |
|
19.3 |
x 10E3 um2 |
4.8 |
19.79 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
|
107461 |
2378 |
SHR-Chr 8MWF/Rkb |
urine albumin excretion rate |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
urine albumin amount |
male |
168 days
| 15 |
|
37.2 |
mg/d |
4.9 |
18.98 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109565 |
3148 |
SHR-Chr 8MWF/Rkb |
plasma cystatin C level |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
blood cystatin C amount |
male |
168 days
| 15 |
|
0.07 |
mg/l |
0.0 |
0.01 |
automated plasma protein analysis |
|
0.0 |
|
0 |
|
|
|
|
109569 |
3148 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 16 |
|
11.7 |
x 10E3 um2 |
2.9 |
11.6 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
|
|
107514 |
2378 |
ACI.FHH-(D1Rat384-D1Rat156)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168 days-175 days |
11 |
|
42.0 |
% |
6.0 |
19.9 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
68883 |
832 |
FHH/Eur |
urine albumin excretion rate to body weight ratio |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
urine albumin amount |
male |
91 days-98 days |
26 |
|
57.6 |
mg/d/100 g |
3.49 |
17.8 |
bromocresol green-based urine albumin analysis with spectrophotometric readout |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
|
|
69157 |
1128 |
SD |
body weight |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 11 |
|
277.0 |
g |
8.14 |
27.0 |
body weighing method |
|
0.0 |
unx |
13 |
days |
|
|
|
101536 |
2602 |
SD |
change in body weight |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 11 |
|
66.0 |
g |
7.84 |
26.0 |
body weighing method |
|
0.0 |
unx |
13 |
days |
|
change from surgery weight |
|
101540 |
2602 |
SD |
heart wet weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
heart mass |
male |
0 days
| 7 |
|
0.88 |
g |
0.04 |
0.11 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101589 |
2602 |
SD |
plasma potassium level |
unilateral nephrectomy (for 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
blood potassium amount |
male |
0 days
| 8 |
|
5.3 |
mmol/l |
0.14 |
0.4 |
ex vivo blood analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101625 |
2602 |
SD |
plasma potassium level |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
blood potassium amount |
male |
0 days
| 6 |
|
4.5 |
mmol/l |
0.2 |
0.5 |
ex vivo blood analysis |
|
0.0 |
unx |
28 |
days |
|
|
|
101598 |
2602 |
SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 12 |
|
0.93 |
mg/dl |
0.02 |
0.07 |
serum creatinine analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100638 |
2499 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 17 |
|
324.0 |
mg/dl |
13.0 |
53.6 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
99971 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 16 |
|
308.0 |
mg/dl |
15.0 |
60.0 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
99973 |
2378 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 11 |
|
45.2 |
% |
1.4 |
4.64 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
|
99975 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 17 |
|
0.29 |
null |
0.01 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99986 |
2378 |
MW |
body weight |
unilateral nephrectomy (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 6 |
|
237.0 |
g |
12.0 |
29.39 |
body measuring method |
|
0.0 |
unx |
42 |
days |
|
|
|
101145 |
2581 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 6 |
undefined |
122.0 |
mmHg |
3.0 |
7.35 |
tail cuff plethysmography |
|
0.0 |
unx |
70 |
days |
|
|
|
101167 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 7 |
|
11.0 |
mg/d |
2.0 |
5.29 |
Bradford protein assay |
|
0.0 |
unx |
14 |
days |
|
|
|
101192 |
2581 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
2.33 |
ml/min/100g |
0.09 |
0.25 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99952 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 8 |
|
38.02 |
ml/d |
5.33 |
15.07 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
|
99967 |
2378 |
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur |
body weight |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
body mass |
male |
173 days-180 days |
10 |
|
301.0 |
g |
4.0 |
12.65 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67679 |
751 |
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur |
body weight |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
body mass |
male |
173 days-180 days |
9 |
|
284.0 |
g |
6.0 |
18.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67682 |
751 |
ACI/Eur |
plasma albumin level |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood albumin amount |
male |
173 days-180 days |
11 |
|
27.9 |
g/l |
0.3 |
0.99 |
bromocresol green-based urine albumin analysis with spectrophotometric readout |
|
0.0 |
|
0 |
|
bromocresol green |
|
|
68029 |
751 |
ACI.FHH-(D1Rat324-D1Rat156)/Eur |
plasma albumin level |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood albumin amount |
male |
173 days-180 days |
8 |
|
24.0 |
g/l |
1.0 |
2.83 |
bromocresol green-based urine albumin analysis with spectrophotometric readout |
|
0.0 |
|
0 |
|
bromocresol green |
% glomerulosclerosis |
|
68031 |
751 |
FHH/Eur |
urine total protein excretion rate to body weight ratio |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
total urine protein amount |
male |
91 days-98 days |
26 |
|
77.2 |
mg/d/100 g |
4.0 |
20.4 |
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
urine TOTAL protein excretion rate to body weight ratio |
|
69155 |
1128 |
ACI/Eur |
body weight |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168 days-175 days |
12 |
|
314.0 |
g |
5.0 |
17.32 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
|
67907 |
832 |
ACI/Eur |
plasma creatinine level |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood creatinine amount |
male |
173 days-180 days |
8 |
|
0.61 |
mg/dl |
0.02 |
0.06 |
plasma creatinine analysis by Jaffe reaction without deproteinization with spectrophotometric readout |
|
0.0 |
|
0 |
|
Jaffe method colorimetric spectrometry |
|
|
68002 |
751 |
ACI.FHH-(D1Rat324-D1Rat156)/Eur |
plasma creatinine level |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood creatinine amount |
male |
173 days-180 days |
8 |
|
0.59 |
mg/dl |
0.01 |
0.03 |
plasma creatinine analysis by Jaffe reaction without deproteinization with spectrophotometric readout |
|
0.0 |
|
0 |
|
Jaffe method colorimetric spectrometry |
|
|
68004 |
751 |
ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168 days-175 days |
2 |
|
59.0 |
% |
11.0 |
15.56 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
68884 |
832 |
ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168 days-175 days |
12 |
|
20.0 |
% |
3.0 |
10.39 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
68882 |
832 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 16 |
|
317.0 |
mg/dl |
19.0 |
76.0 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
|
99974 |
2378 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 17 |
|
44.8 |
% |
0.6 |
2.47 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
|
99976 |
2378 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 17 |
|
45.6 |
% |
0.3 |
1.24 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
|
99977 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 17 |
|
0.5 |
ml/min/100g |
0.03 |
0.12 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99981 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 16 |
|
0.21 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99989 |
2378 |
SD |
adrenal gland weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
adrenal gland mass |
male |
0 days
| 8 |
|
71.0 |
mg |
1.41 |
4.0 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101627 |
2602 |
SD |
plasma potassium level |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
blood potassium amount |
male |
0 days
| 7 |
|
5.0 |
mmol/l |
0.15 |
0.4 |
ex vivo blood analysis |
|
0.0 |
unx |
28 |
days |
|
|
|
101596 |
2602 |
SD |
adrenal gland weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
adrenal gland mass |
male |
0 days
| 7 |
|
57.0 |
mg |
1.51 |
4.0 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101601 |
2602 |
SD |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney glomerulus integrity trait |
male |
0 days
| 7 |
|
37.2 |
% |
10.02 |
26.5 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
28 |
days |
|
|
|
101604 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 11 |
undefined |
185.0 |
mmHg |
7.84 |
26.0 |
tail cuff plethysmography |
|
0.0 |
unx |
13 |
days |
|
- |
|
101548 |
2602 |
SD |
plasma aldosterone level |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
blood aldosterone amount |
male |
0 days
| 5 |
|
181.0 |
pg/ml |
55.45 |
124.0 |
plasma aldosterone analysis |
|
0.0 |
unx |
13 |
days |
|
|
|
101557 |
2602 |
SD |
adrenal gland weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
adrenal gland mass |
male |
0 days
| 5 |
|
56.0 |
mg |
1.79 |
4.0 |
post excision weight measurement |
|
0.0 |
unx |
13 |
days |
|
|
|
101561 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 7 |
|
307.0 |
g |
36.66 |
25.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
101573 |
2602 |
SD |
change in body weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 7 |
|
96.0 |
g |
15.12 |
40.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
change from surgery weight |
|
101576 |
2602 |
SD |
left kidney wet weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney mass |
male |
0 days
| 6 |
|
2.03 |
g |
0.2 |
0.48 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
remnant kidney |
|
101582 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 7 |
undefined |
212.0 |
mmHg |
7.56 |
20.0 |
tail cuff plethysmography |
|
0.0 |
unx |
28 |
days |
|
|
|
101584 |
2602 |
SD |
heart wet weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
heart mass |
male |
0 days
| 6 |
|
1.28 |
g |
0.05 |
0.12 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101590 |
2602 |
MW |
body weight |
unilateral nephrectomy (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 6 |
|
224.0 |
g |
9.0 |
22.05 |
body measuring method |
|
0.0 |
unx |
14 |
days |
|
|
|
101141 |
2581 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 6 |
undefined |
122.0 |
mmHg |
4.0 |
9.8 |
tail cuff plethysmography |
|
0.0 |
unx |
14 |
days |
|
|
|
101158 |
2581 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 5 |
|
31.0 |
mg/dl |
1.0 |
2.24 |
blood urea nitrogen analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101183 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 5 |
|
320.0 |
mg/d |
146.0 |
326.47 |
Bradford protein assay |
|
0.0 |
unx |
42 |
days |
|
|
|
101197 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 6 |
|
348.0 |
mg/d |
84.0 |
205.76 |
Bradford protein assay |
|
0.0 |
unx |
70 |
days |
|
|
|
101199 |
2581 |
SHR/NCrlCrlj |
blood potassium level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood potassium amount |
male |
126 days
| 9 |
|
5.1 |
mmol/l |
0.3 |
0.9 |
automated serum potassium test |
|
0.0 |
unx |
42 |
days |
|
|
|
101244 |
2583 |
SHR/NCrlCrlj |
blood urea nitrogen level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood urea nitrogen amount |
male |
126 days
| 8 |
|
54.0 |
mg/dl |
5.0 |
14.14 |
blood urea nitrogen analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101251 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 14 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
98 days
| 10 |
|
0.36 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101255 |
2583 |
SHR/NCrlCrlj |
plasma aldosterone level |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood aldosterone amount |
male |
126 days
| 5 |
|
389.0 |
pg/ml |
86.0 |
192.3 |
plasma aldosterone analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101266 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin I level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin I amount |
male |
126 days
| 9 |
|
279.0 |
pg/ml |
21.0 |
63.0 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
|
101272 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin I level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin I amount |
male |
126 days
| 5 |
|
281.0 |
pg/ml |
41.0 |
91.68 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
|
101273 |
2583 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 8 |
|
233.0 |
g |
5.0 |
14.14 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
99938 |
2378 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 6 |
|
229.0 |
g |
6.0 |
14.7 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
99939 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 8 |
|
350.0 |
mg/dl |
18.0 |
50.91 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
99941 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 8 |
|
357.0 |
mg/dl |
11.0 |
31.11 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
99943 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.23 |
null |
0.12 |
0.34 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99957 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.23 |
null |
0.14 |
0.4 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99958 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 8 |
|
23.47 |
ml/d |
1.73 |
4.89 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
|
99966 |
2378 |
ACI.FHH-(rgdv393055223-rs107095981)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91 days
| 5 |
|
188.71 |
mg/d |
20.03 |
44.79 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-3 |
|
100054 |
2400 |
ACI.FHH-(rs105487995-rs105373896)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91 days
| 8 |
|
18.95 |
mg/d |
2.93 |
8.29 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-1 |
|
100060 |
2400 |
SBN/Ygl |
urine total protein excretion rate |
unilateral nephrectomy (for 150 days) |
Yagil Y, et al., Physiol Genomics. 2010 Nov 29;42A(4):301-16. Epub 2010 Sep 28. |
total urine protein amount |
female |
170 days
| 7 |
|
7.0 |
mg/d |
3.0 |
7.94 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
|
106691 |
3037 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 16 |
|
11.1 |
x 10E3 um2 |
2.8 |
11.2 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
|
107513 |
2378 |
SHR/FubRkb |
body weight |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
body mass |
male |
168 days
| 15 |
|
330.4 |
g |
6.0 |
23.24 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
109550 |
3148 |
SHR/FubRkb |
right kidney wet weight to body weight ratio |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
kidney mass |
male |
168 days
| 15 |
|
5.02 |
mg/g |
0.16 |
0.62 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
|
109559 |
3148 |
SHR-Chr 8MWF/Rkb |
right kidney wet weight to body weight ratio |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
kidney mass |
male |
168 days
| 15 |
|
4.71 |
mg/g |
0.09 |
0.35 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
|
109560 |
3148 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 17 |
|
274.0 |
g |
6.0 |
24.74 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
|
107447 |
2378 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 17 |
|
8.2 |
mg/g |
0.2 |
0.82 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107457 |
2378 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 11 |
|
8.7 |
x 10E3 um2 |
2.6 |
8.62 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
|
|
107510 |
2378 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 16 |
|
8.3 |
mg/g |
0.2 |
0.8 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107459 |
2378 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 11 |
|
3.9 |
mg/g |
0.1 |
0.33 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107455 |
2378 |
ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
kidney glomerulus integrity trait |
male |
173 days-180 days |
11 |
|
13.0 |
% |
2.0 |
6.63 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
|
|
67959 |
751 |
SD |
change in body weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 7 |
|
97.0 |
g |
7.56 |
20.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
change from surgery weight |
|
101577 |
2602 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 16 |
|
0.67 |
ml/min/100g |
0.02 |
0.08 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99984 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 17 |
|
6.6 |
mmHg/ml/min |
0.3 |
1.24 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99997 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 16 |
|
6.8 |
mmHg/ml/min |
0.3 |
1.2 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99999 |
2378 |
MW |
body weight |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 5 |
|
232.0 |
g |
6.0 |
13.42 |
body measuring method |
|
0.0 |
unx |
14 |
days |
|
|
|
101143 |
2581 |
MW |
body weight |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 5 |
|
207.0 |
g |
17.0 |
38.01 |
body measuring method |
|
0.0 |
unx |
42 |
days |
|
|
|
101147 |
2581 |
MW |
systolic blood pressure |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 5 |
undefined |
100.0 |
mmHg |
4.0 |
8.94 |
tail cuff plethysmography |
|
0.0 |
unx |
70 |
days |
|
|
|
101169 |
2581 |
MW |
mean arterial blood pressure |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 6 |
undefined |
105.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
unx |
70 |
days |
|
|
|
101172 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 5 |
|
271.0 |
mg/d |
131.0 |
292.92 |
Bradford protein assay |
|
0.0 |
unx |
70 |
days |
|
|
|
101201 |
2581 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
0.54 |
ml/min/100g |
0.02 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99948 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
9.0 |
mmHg/ml/min |
0.4 |
1.13 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99961 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 6 |
|
44.93 |
ml/d |
8.78 |
21.52 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
|
99969 |
2378 |
ACI.FHH-(D1Rat324-D1Rat156)/Eur |
body weight |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
body mass |
male |
173 days-180 days |
8 |
|
235.0 |
g |
9.0 |
25.46 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67683 |
751 |
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur |
plasma creatinine level |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood creatinine amount |
male |
173 days-180 days |
9 |
|
0.74 |
mg/dl |
0.02 |
0.07 |
plasma creatinine analysis by Jaffe reaction without deproteinization with spectrophotometric readout |
|
0.0 |
|
0 |
|
Jaffe method colorimetric spectrometry |
|
|
68006 |
751 |
ACI.FHH-(D1Rat324-D1Rat156)/Eur |
plasma creatinine level |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood creatinine amount |
male |
173 days-180 days |
8 |
|
1.33 |
mg/dl |
0.24 |
0.67 |
plasma creatinine analysis by Jaffe reaction without deproteinization with spectrophotometric readout |
|
0.0 |
|
0 |
|
Jaffe method colorimetric spectrometry |
% glomerulosclerosis |
|
68007 |
751 |
ACI/Eur |
plasma albumin level |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood albumin amount |
male |
173 days-180 days |
8 |
|
29.4 |
g/l |
0.5 |
1.41 |
bromocresol green-based urine albumin analysis with spectrophotometric readout |
|
0.0 |
|
0 |
|
bromocresol green |
|
|
68026 |
751 |
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur |
plasma albumin level |
unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood albumin amount |
male |
173 days-180 days |
10 |
|
28.3 |
g/l |
0.6 |
1.9 |
bromocresol green-based urine albumin analysis with spectrophotometric readout |
|
0.0 |
|
0 |
|
bromocresol green |
|
|
68027 |
751 |
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur |
plasma albumin level |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
blood albumin amount |
male |
173 days-180 days |
9 |
|
28.7 |
g/l |
0.6 |
1.8 |
bromocresol green-based urine albumin analysis with spectrophotometric readout |
|
0.0 |
|
0 |
|
bromocresol green |
|
|
68030 |
751 |
ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur |
body weight |
unilateral nephrectomy |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168 days-175 days |
12 |
|
304.0 |
g |
2.0 |
6.93 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
|
67901 |
832 |
ACI.FHH-(D1Rat384-D1Rat156)/Eur |
body weight |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168 days-175 days |
11 |
|
267.0 |
g |
11.0 |
36.48 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
|
67908 |
832 |
ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur |
body weight |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168 days-175 days |
2 |
|
286.0 |
g |
1.0 |
1.41 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
|
67909 |
832 |
ACI.FHH-(D1Rat324-D1Rat156)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) |
Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. |
kidney glomerulus integrity trait |
male |
173 days-180 days |
8 |
|
41.0 |
% |
9.0 |
25.46 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
% glomerulosclerosis |
|
67961 |
751 |
SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 13 |
|
283.6 |
g |
3.8 |
13.7 |
body weighing method |
|
0.0 |
unx |
97 |
days |
|
|
|
100632 |
2499 |
SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 12 |
|
0.58 |
ml/min |
0.05 |
0.17 |
serum creatinine analysis |
|
0.0 |
unx |
97 |
days |
|
|
|
100645 |
2499 |
SHR/NCrlCrlj |
plasma angiotensin II level to plasma angiotensin I level ratio |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin II amount |
male |
126 days
| 5 |
|
0.8 |
null |
0.13 |
0.29 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
blood ang II level |
101278 |
2583 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 17 |
|
16.7 |
mmHg/ml/min |
1.4 |
5.77 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99996 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 16 |
|
7.1 |
mmHg/ml/min |
0.3 |
1.2 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99998 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 11 |
|
11.66 |
ml/d |
1.01 |
3.34 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
|
100000 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 16 |
|
45.5 |
ml/d |
5.04 |
20.16 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
|
100003 |
2378 |
SD |
body weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 5 |
|
302.0 |
g |
6.26 |
14.0 |
body weighing method |
|
0.0 |
unx |
13 |
days |
|
|
|
101538 |
2602 |
SD |
change in body weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 5 |
|
66.0 |
g |
4.92 |
11.0 |
body weighing method |
|
0.0 |
unx |
13 |
days |
|
change from surgery weight |
|
101542 |
2602 |
SD |
plasma renin activity level |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
renin activity |
male |
0 days
| 11 |
|
4.3 |
ng/ml/h |
0.63 |
2.08 |
radioimmunoassay |
|
0.0 |
unx |
13 |
days |
|
- |
|
101564 |
2602 |
SD |
change in body weight |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 8 |
|
48.0 |
g |
10.96 |
31.0 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
change from surgery weight |
|
101610 |
2602 |
SD |
left kidney wet weight |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney mass |
male |
0 days
| 8 |
|
1.79 |
g |
0.12 |
0.35 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101614 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (for 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
201.0 |
mmHg |
6.72 |
19.0 |
tail cuff plethysmography |
|
0.0 |
unx |
14 |
days |
|
|
|
101615 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
208.0 |
mmHg |
6.01 |
17.0 |
tail cuff plethysmography |
|
0.0 |
unx |
28 |
days |
|
|
|
101617 |
2602 |
SD |
heart wet weight |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
heart mass |
male |
0 days
| 8 |
|
1.21 |
g |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101620 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 8 |
|
243.0 |
mg/d |
26.16 |
74.0 |
urine protein analysis |
|
0.0 |
unx |
28 |
days |
|
|
|
101624 |
2602 |
SD |
adrenal gland weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
adrenal gland mass |
male |
0 days
| 7 |
|
69.0 |
mg |
3.4 |
9.0 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101600 |
2602 |
SD |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney glomerulus integrity trait |
male |
0 days
| 6 |
|
25.3 |
% |
4.53 |
11.1 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
28 |
days |
|
|
|
101606 |
2602 |
SHR/NCrlCrlj |
blood urea nitrogen level |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood urea nitrogen amount |
male |
126 days
| 5 |
|
72.0 |
mg/dl |
5.0 |
11.18 |
blood urea nitrogen analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101250 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 14 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
98 days
| 6 |
|
0.33 |
ml/min/100g |
0.06 |
0.15 |
blood creatinine analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101257 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
126 days
| 5 |
|
0.14 |
ml/min/100g |
0.03 |
0.06 |
blood creatinine analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101258 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
126 days
| 8 |
|
0.33 |
ml/min/100g |
0.05 |
0.15 |
blood creatinine analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101259 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
126 days
| 9 |
|
0.33 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101260 |
2583 |
SHR/NCrlCrlj |
plasma aldosterone level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood aldosterone amount |
male |
126 days
| 8 |
|
492.0 |
pg/ml |
46.0 |
130.11 |
plasma aldosterone analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101267 |
2583 |
SHR/NCrlCrlj |
plasma angiotensin II level |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood angiotensin II amount |
male |
126 days
| 5 |
|
11.6 |
pg/ml |
2.1 |
4.7 |
radioimmunoassay |
|
0.0 |
unx |
42 |
days |
|
|
blood ang II level |
101274 |
2583 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 6 |
|
41.0 |
mg/dl |
3.0 |
7.35 |
blood urea nitrogen analysis |
|
0.0 |
unx |
70 |
days |
|
|
|
101186 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 6 |
|
7.0 |
mg/d |
1.0 |
2.45 |
Bradford protein assay |
|
0.0 |
unx |
14 |
days |
|
|
|
101191 |
2581 |
MW |
urine total protein excretion rate |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
total urine protein amount |
male |
0 days
| 5 |
|
10.0 |
mg/d |
2.0 |
4.47 |
Bradford protein assay |
|
0.0 |
unx |
14 |
days |
|
|
|
101193 |
2581 |
SHR/NCrlCrlj |
blood sodium level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood sodium amount |
male |
126 days
| 9 |
|
140.0 |
mmol/l |
1.0 |
3.0 |
automated serum sodium test |
|
0.0 |
unx |
42 |
days |
|
|
|
101240 |
2583 |
ACI.FHH-(rs198076037-rs105278863)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91 days
| 5 |
|
154.55 |
mg/d |
13.31 |
29.76 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-7 |
|
100058 |
2400 |
ACI/EurMcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91 days
| 9 |
|
19.16 |
mg/d |
5.53 |
16.59 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
|
|
100059 |
2400 |
ACI.FHH-(rgdv393055223-rs198922144)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91 days
| 7 |
|
74.0 |
mg/d |
8.91 |
23.57 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-4 |
|
100063 |
2400 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 7 |
|
268.0 |
g |
13.0 |
34.39 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
99935 |
2378 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 8 |
|
236.0 |
g |
7.0 |
19.8 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
|
99937 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 8 |
|
352.0 |
mg/dl |
17.0 |
48.08 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
|
99942 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 6 |
|
0.5 |
ml/min/100g |
0.02 |
0.06 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99949 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
3.09 |
ml/min/100g |
0.18 |
0.51 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99951 |
2378 |
SBH/Ygl |
urine total protein excretion rate |
unilateral nephrectomy (for 120 days) |
Yagil Y, et al., Physiol Genomics. 2010 Nov 29;42A(4):301-16. Epub 2010 Sep 28. |
total urine protein amount |
male |
140 days
| 6 |
|
212.0 |
mg/d |
23.0 |
56.34 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
|
106685 |
3037 |
SHR-Chr 8MWF/Rkb |
body weight |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
body mass |
male |
168 days
| 15 |
|
336.5 |
g |
6.7 |
25.95 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
109552 |
3148 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 16 |
|
3.1 |
g/kg |
0.1 |
0.4 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107453 |
2378 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 11 |
|
408.0 |
g |
10.0 |
33.17 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
|
107445 |
2378 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 17 |
|
9.9 |
mg/g |
0.7 |
2.89 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
|
107456 |
2378 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 17 |
|
11.8 |
x 10E3 um2 |
2.9 |
11.96 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
|
107512 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 11 |
|
12.6 |
x 10E3 um2 |
3.8 |
12.6 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
|
107460 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 16 |
|
15.8 |
x 10E3 um2 |
4.0 |
16.0 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
|
107463 |
2378 |
ACI/Eur |
body weight |
unilateral nephrectomy |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168 days-175 days |
12 |
|
314.0 |
g |
3.0 |
10.39 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
|
67899 |
832 |
ACI/Eur |
body weight |
unilateral nephrectomy |
Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78. |
body mass |
male |
91 days-98 days |
21 |
|
242.0 |
g |
3.06 |
14.0 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
39 |
days |
performed at 5 to 6 weeks of age |
|
|
69139 |
1128 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 11 |
|
0.52 |
ml/min/100g |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99980 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 17 |
|
1.72 |
ml/min/100g |
0.11 |
0.45 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99991 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 11 |
|
6.3 |
mmHg/ml/min |
0.4 |
1.33 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
|
99995 |
2378 |
MW |
body weight |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
body mass |
male |
0 days
| 7 |
|
286.0 |
g |
9.0 |
23.81 |
body measuring method |
|
0.0 |
unx |
70 |
days |
|
|
|
101154 |
2581 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 7 |
|
25.0 |
mg/dl |
1.0 |
2.65 |
blood urea nitrogen analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101178 |
2581 |
MW |
blood urea nitrogen level |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
0 days
| 7 |
|
25.0 |
mg/dl |
3.0 |
7.94 |
blood urea nitrogen analysis |
|
0.0 |
unx |
42 |
days |
|
|
|
101182 |
2581 |
MW |
glomerular filtration rate |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 7 |
|
1.46 |
ml/min |
0.08 |
0.21 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
70 |
days |
|
|
|
101205 |
2581 |
SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 12 |
|
281.9 |
g |
4.2 |
14.55 |
body weighing method |
|
0.0 |
unx |
97 |
days |
|
|
|
100633 |
2499 |
SD |
left kidney wet weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney mass |
male |
0 days
| 5 |
|
1.16 |
g |
0.11 |
0.25 |
post excision weight measurement |
|
0.0 |
unx |
13 |
days |
|
remnant kidney |
|
101545 |
2602 |
SD |
systolic blood pressure |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
0 days
| 5 |
undefined |
125.0 |
mmHg |
6.26 |
14.0 |
tail cuff plethysmography |
|
0.0 |
unx |
13 |
days |
|
|
|
101549 |
2602 |
SD |
urine total protein excretion rate |
unilateral nephrectomy (for 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
total urine protein amount |
male |
0 days
| 8 |
|
201.0 |
mg/d |
31.47 |
89.0 |
urine protein analysis |
|
0.0 |
unx |
14 |
days |
|
|
|
101621 |
2602 |
SD |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
kidney glomerulus integrity trait |
male |
0 days
| 8 |
|
26.0 |
% |
3.89 |
11.0 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
28 |
days |
|
|
|
101630 |
2602 |
SD |
adrenal gland weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
adrenal gland mass |
male |
0 days
| 6 |
|
60.0 |
mg |
3.27 |
8.0 |
post excision weight measurement |
|
0.0 |
unx |
28 |
days |
|
|
|
101602 |
2602 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 6 |
|
2.42 |
ml/min/100g |
0.09 |
0.22 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
|
99954 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 7 |
|
12.38 |
ml/d |
2.02 |
5.33 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
|
99965 |
2378 |